Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating rheumatism and rheumatoid

A rheumatoid and drug technology, applied in the field of medicine, can solve the problems of long course of treatment, low cure rate, and large side effects, and achieve the effects of inhibiting synthesis and secretion, relieving joint pain, and relieving joint swelling

Pending Publication Date: 2016-06-01
程龙
View PDF6 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Western medicine is quick to take effect, but it can cure the symptoms but not the root cause, and the drug will relapse immediately after stopping the drug. The side effects are huge, and it is easy to cause life-long diseases and complications, such as damage to the nervous system, liver and kidneys and other internal organs, resulting in endocrine disorders and gastric bleeding embolism. Disadvantages such as single curative effect, slow effect, low cure rate, and long course of treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating rheumatism and rheumatoid
  • Medicine for treating rheumatism and rheumatoid
  • Medicine for treating rheumatism and rheumatoid

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Embodiment 1 A kind of medicine for treating rheumatic rheumatism

[0030] The drug is marine algae glycoprotein;

[0031] Said marine algae glycoprotein, by weight content, comprises sugar 1%, protein 99%,

[0032] The molecular weight is 0.2kDa;

[0033] The marine algae are: cyanobacteria;

[0034] The sugar is a polysaccharide;

[0035] The polysaccharides include: glucose, mannose, rhamnose, galactose;

[0036] The protein includes: aspartic acid, glutamic acid, glycine, arginine, lysine, serine, threonine.

Embodiment 2

[0037] Embodiment 2 A kind of medicine for treating rheumatic rheumatoid

[0038] The drug is marine algae glycoprotein;

[0039] Said marine algae glycoprotein, by weight content, comprises sugar 10%, protein 80%,

[0040] The molecular weight is 13kDa;

[0041] The marine algae is: green algae;

[0042] The sugar is a polysaccharide;

[0043] The polysaccharides include: glucose, mannose, rhamnose, galactose;

[0044] The protein includes: aspartic acid, glutamic acid, glycine, arginine, lysine, serine, threonine.

Embodiment 3

[0045] Embodiment 3 A kind of medicine for treating rheumatic rheumatoid

[0046] The drug is marine algae glycoprotein;

[0047] Said marine algal glycoprotein, by weight content, comprises sugar 20%, protein 72%,

[0048] The molecular weight is 5kDa;

[0049] The marine algae are: cyanobacteria;

[0050] The sugar is a polysaccharide;

[0051] The polysaccharides include: glucose, mannose, rhamnose, galactose;

[0052] The protein includes: aspartic acid, glutamic acid, glycine, arginine, lysine, serine, threonine.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Molecular weightaaaaaaaaaa
Molecular weightaaaaaaaaaa
Molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention provides medicine for treating rheumatism and rheumatoid. The medicine is glycoprotein, mixture of polysaccharide and protein, polypeptide or protein. The medicine has the advantages that the joint pain of rat rheumatic arthritis can be relieved effectively, and the joint pain threshold is increased evidently; the joint swelling of the rat rheumatic arthritis can be evidently relieved; rat hypothalamus L-ENK and beta-END contents can be increased, the secretion of proinflammatory factors such as IL-1beta and IL-6 can be lowered, the synthesizing and secretion of serum immunoglobulin IgG can be inhibited, and the release of pain excitation factor SP can be inhibited; the medicine is safe, efficient, free of side effect, and capable of preventing the pantalgia, joint pain and muscle pain caused by the rheumatism and rheumatoid, the joint swelling and pain, joint pain, neck and shoulder pain and waist and back pain not caused by trauma, and the joint pain caused by gout.

Description

technical field [0001] The invention relates to a medicine for treating rheumatism and rheumatoid, belonging to the technical field of medicine. Background technique [0002] Rheumatism and rheumatoid diseases are "stubborn", "difficult" and "very troublesome". They can't be cured for a long time, and they attack repeatedly, which makes patients suffer and doctors have headaches. According to the report of the World Center for Disease Control: Rheumatism and rheumatoid diseases are another intractable disease that seriously threatens human health after cancer. At present, in the United States, Europe and Japan, the number of patients with rheumatism and rheumatoid diseases is as high as nearly 300 million. A survey in some areas of my country shows that 85% of people over the age of 45 suffer from this disease to varying degrees, and the medical expenses paid for it are as high as hundreds of millions of yuan, and there is a further increasing trend. If treatment is delayed...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/16A61K31/715A61K31/7012A61P29/00A61K36/02
CPCA61K31/7105A61K38/16A61K31/7012A61K31/715A61K36/02A61K36/195A61K36/315A61K36/484A61K36/634A61K36/66A61K36/704A61K2300/00
Inventor 程龙徐宝贞程潜
Owner 程龙
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com